Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Coloplast A/S    COLO B   DK0060448595

COLOPLAST A/S

(COLO B)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Copenhagen
11/26/2020 11/27/2020 11/30/2020 12/01/2020 12/02/2020 Date
905(c) 929.8(c) 931.6(c) 911.6(c) 919.2 Last
251 790 283 544 1 029 691 329 740 76 032 Volume
+0.71% +2.74% +0.19% -2.15% +0.83% Change
More quotes
Financials
Sales 2021 19 573 M 3 178 M 3 178 M
Net income 2021 4 735 M 769 M 769 M
Net Debt 2021 1 318 M 214 M 214 M
P/E ratio 2021 41,0x
Yield 2021 2,07%
Sales 2022 21 170 M 3 438 M 3 438 M
Net income 2022 5 168 M 839 M 839 M
Net Debt 2022 1 209 M 196 M 196 M
P/E ratio 2022 37,6x
Yield 2022 2,29%
Capitalization 194 B 31 361 M 31 482 M
EV / Sales 2021 9,97x
EV / Sales 2022 9,22x
Nbr of Employees 12 427
Free-Float 57,3%
More Financials
Company
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (49.1%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (39.9%): bags and equipment used following intestinal operations; - wound care and skincare products (13%): wound dressings, bandages, creams and... 
More about the company
Notations Surperformance© of Coloplast A/S
Trading Rating : Investor Rating :
More Ratings
All news about COLOPLAST A/S
11/10COLOPLAST A/S : - Announcement no. 13/2020 - Notice of Annual General Meeting
AQ
11/05COLOPLAST A/S : - Trading in Coloplast shares by board members, executives or as..
AQ
11/04COLOPLAST A/S : Group - delivers solid full year results despite the COVID-19 pa..
AQ
11/04COLOPLAST A/S : acquires Nine Continents Medical, Inc.
AQ
11/03GLOBAL MARKETS LIVE: Ant Group’s IPO postponed; Deutsche Bank wants to get ri..
11/03COLOPLAST A/S : Buys Nine Continents Medical for Initial $145 Million
DJ
11/03COLOPLAST A/S : - Announcement no. 12/2020 - Sustainability Report 2019/20
AQ
11/03COLOPLAST A/S : - Announcement no. 11/2020 – Annual Report 2019/20 & Remun..
AQ
11/03COLOPLAST A/S : acquires Nine Continents Medical, Inc.
AQ
11/03Coloplast acquires Nine Continents Medical, Inc.
GL
11/03COLOPLAST A/S : delivers solid full year results despite the COVID-19 pandemic a..
AQ
11/03COLOPLAST A/S : - Announcement no. 10/2020 - Full-year Financial Results 2019/20
AQ
11/03COLOPLAST A/S : Annual results
CO
10/29COLOPLAST A/S : annual earnings release
09/30COLOPLAST A/S : completes minority investment in Francis Medical
AQ
More news
News in other languages on COLOPLAST A/S
11/06Les marchés s'en fichent, vraiment ?
11/06AVIS D'ANALYSTES DU JOUR : ArcelorMittal, Casino, Crédit Agricole, Getinge, Lanx..
11/03Rien ne va plus, les jeux ne sont pas encore faits
11/03EN DIRECT DES MARCHES : BNP Paribas, EssilorLuxottica, Carrefour, Adecco, HelloF..
10/29COLOPLAST A/S : publication des résultats annuels
More news
Chart COLOPLAST A/S
Duration : Period :
Coloplast A/S Technical Analysis Chart | COLO B | DK0060448595 | MarketScreener
Technical analysis trends COLOPLAST A/S
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Average target price 940,11 DKK
Last Close Price 911,60 DKK
Spread / Highest target 25,3%
Spread / Average Target 3,13%
Spread / Lowest Target -17,2%
EPS Revisions
Managers
NameTitle
Kristian Villumsen President & Chief Executive Officer
Lars Søren Rasmussen Chairman
Allan Rasmussen Executive Vice President-Global Operations
Anders Lonning-Skovgaard Chief Financial Officer & Executive Vice President
Oliver Johansen Senior VP-Global Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
COLOPLAST A/S10.31%31 361
TELEFLEX INCORPORATED1.07%17 717
TOP GLOVE CORPORATION BHD.354.47%13 390
HARTALEGA HOLDINGS162.77%12 185
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED71.73%9 124
SUPERMAX CORPORATION1,209.35%5 547